Kano A
Nihon Sanka Fujinka Gakkai Zasshi. 1983 Dec;35(12):2311-20.
Pathogenesis of toxemia of pregnancy has been studied of late in terms of coagulation and fibrinolysis, and the results show evidence of hypercoagulability but not of fibrinolysis which has remained unclarified. Our study aims to elucidate the fibrinolytic kinetics of toxemia in normal pregnant women divided into mild and severe types and eclampsia, and also to study changes in the coagulation and fibrinolytic system in toxemia given urokinase. In the affected group the following 1)--3) parameters characteristics were more significant than in other groups. 1) Decreased platelet count. 2) Prolonged ELT. 3) Increased AT-III. 4) There was no significant difference between the groups examined in PT, APTT, Fbg., serum FDP, alpha 2-antipl., alpha 1-AT, alpha 2-MG, C1-INA, and plg. 5) Signs in eclampsia, with region slightly distributed, tended to resemble those in the serious group. 6) alpha 2-antipl., and alpha 1-AT in the case given urokinase tended to decrease. 7) There was observed a case of accelerating and lowering fibrinolysis that appeared simultaneously with the following signs: decreased alpha 2-antipl., increased serum FDP, and prolonged ELT; and also the case whose signs widely changed even after a relatively small dose of urokinase. The results obtained suggest the possibility of variable fibrinolytic kinetics.
近年来,已从凝血和纤溶方面对妊娠毒血症的发病机制进行了研究,结果显示有高凝性的证据,但纤溶情况仍不明确。我们的研究旨在阐明分为轻度和重度类型的正常孕妇及子痫患者妊娠毒血症的纤溶动力学,同时研究给予尿激酶后妊娠毒血症患者凝血和纤溶系统的变化。在患病组中,以下1)-3)参数特征比其他组更显著。1)血小板计数降低。2)优球蛋白溶解时间延长。3)抗凝血酶III增加。4)在凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、血清纤维蛋白降解产物、α2-抗纤溶酶、α1-抗胰蛋白酶、α2-巨球蛋白、C1酯酶抑制物和纤溶酶原方面,各检查组之间无显著差异。5)子痫的体征,分布区域略有不同,倾向于与重度组相似。6)给予尿激酶的病例中,α2-抗纤溶酶和α1-抗胰蛋白酶倾向于降低。7)观察到一例纤溶加速和降低同时出现以下体征的病例:α2-抗纤溶酶降低、血清纤维蛋白降解产物增加和优球蛋白溶解时间延长;还有一例在给予相对小剂量尿激酶后体征发生广泛变化的病例。所获得的结果提示纤溶动力学存在变化的可能性。